Cargando…

Factors associated with favorable survival outcomes for Asians with hepatocellular carcinoma: A sequential matching cohort study

BACKGROUND: Overall 5-year survival rates for patients diagnosed with hepatocellular carcinoma (HCC) are poor, but vary by race/ethnicity. We undertook a comprehensive assessment of underlying contributing factors to the favorable survival outcomes of HCC among Asians compared with non-Hispanic whit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhensheng, Gu, Xiangjun, Thrift, Aaron P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447218/ https://www.ncbi.nlm.nih.gov/pubmed/30943273 http://dx.doi.org/10.1371/journal.pone.0214721

Ejemplares similares

Survival Improvements in Advanced Hepatocellular Carcinoma with Sequential Therapy by Era
por: Nakamura, Yoshiko, et al.
Publicado: (2023)

Socioeconomic disadvantage contributes to ethnic disparities in multiple myeloma survival: a matched cohort study
por: Buradagunta, Christopher Staffi, et al.
Publicado: (2022)

Sentinel Lymph Node Biopsy Was Associated With Favorable Survival Outcomes For Patients With Clinically Node-Negative Asian Melanoma
por: Chang, John Wen-Cheng, et al.
Publicado: (2019)

DNASE1L3 as an indicator of favorable survival in hepatocellular carcinoma patients following resection
por: Wang, Shuncong, et al.
Publicado: (2020)

Survival outcomes of hepatocellular carcinoma resection with postoperative complications – a propensity-score-matched analysis
por: Chok, Kenneth S.H., et al.
Publicado: (2017)

Seven-senescence-associated gene signature predicts overall survival for Asian patients with hepatocellular carcinoma
por: Xiang, Xiao-Hong, et al.
Publicado: (2019)

Black patients with multiple myeloma have better survival than white patients when treated equally: a matched cohort study
por: Dong, Jing, et al.
Publicado: (2022)

Overexpression of ZEB2 in Peritumoral Liver Tissue Correlates with Favorable Survival after Curative Resection of Hepatocellular Carcinoma
por: Cai, Mu-Yan, et al.
Publicado: (2012)

The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis
por: Hassanipour, Soheil, et al.
Publicado: (2020)

A prognostic model composed of four long noncoding RNAs predicts the overall survival of Asian patients with hepatocellular carcinoma
por: Gu, Xuefeng, et al.
Publicado: (2020)

Arthroscopy Confers Favorable Clinical Outcomes in Asian Patients with Borderline Developmental Dysplasia of the Hip
por: Yang, Fan, et al.
Publicado: (2023)

Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality
por: Kim, Hyun-seok, et al.
Publicado: (2022)

VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma
por: Zhang, Ming, et al.
Publicado: (2018)

Low P66shc with High SerpinB3 Levels Favors Necroptosis and Better Survival in Hepatocellular Carcinoma
por: Fasolato, Silvano, et al.
Publicado: (2021)

The impact of liver resection on survival outcomes of hepatocellular carcinoma patients with extrahepatic metastases: A propensity score matching study
por: Mao, Kai, et al.
Publicado: (2018)

Expression of Ovol2 is related to epithelial characteristics and shows a favorable clinical outcome in hepatocellular carcinoma
por: Fu, Hui, et al.
Publicado: (2016)

Survival and hepatitis status among Asian Americans with hepatocellular carcinoma treated without liver transplantation
por: Hwang, Jessica P, et al.
Publicado: (2009)

Evolutionary cancer-favoring engineered vaccinia virus for metastatic hepatocellular carcinoma
por: Yoo, So Young, et al.
Publicado: (2017)

Pancreatoduodenectomy with portal vein resection favors the survival time of patients with pancreatic ductal adenocarcinoma: A propensity score matching analysis
por: Xie, Zhi-Bo, et al.
Publicado: (2019)

Somatic Mutations Favorable to Patient Survival Are Predominant in Ovarian Carcinomas
por: Zhang, Wensheng, et al.
Publicado: (2014)

Predictive Factors of Survival and 6-Month Favorable Outcome of Very Severe Head Trauma Patients; a Historical Cohort Study
por: Vathanalaoha, Karin, et al.
Publicado: (2017)

Relative dose intensity over the first four weeks of lenvatinib therapy is a factor of favorable response and overall survival in patients with unresectable hepatocellular carcinoma
por: Kirino, Sakura, et al.
Publicado: (2020)

Concurrent versus Sequential Sorafenib Therapy in Combination with Radiation for Hepatocellular Carcinoma
por: Wild, Aaron T., et al.
Publicado: (2013)

Postoperative survival analysis of hepatocellular carcinoma patients with liver cirrhosis based on propensity score matching
por: Wu, Zhaoqin, et al.
Publicado: (2022)

A propensity score matching study on survival benefits of radiotherapy in patients with inoperable hepatocellular carcinoma
por: Zeng, Hao, et al.
Publicado: (2023)

Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signature
por: Kim, Myung‐Ho, et al.
Publicado: (2022)

Manganese levels and hepatocellular carcinoma: A systematic review and meta-analysis based on Asian cohort
por: Chen, Xiu-Bing, et al.
Publicado: (2019)

Clinical Presentation of Hepatocellular Carcinoma (HCC) in Asian-Americans Versus Non-Asian-Americans
por: Wong, Philip Y., et al.
Publicado: (2010)

Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison
por: Cho, Yuri, et al.
Publicado: (2023)

Survival in untreated hepatocellular carcinoma: A national cohort study
por: Kim, Young Ae, et al.
Publicado: (2021)

The sequential activation of the mitotic microtubule assembly pathways favors bipolar spindle formation
por: Cavazza, Tommaso, et al.
Publicado: (2016)

Factors associated with the survival outcomes of patients with untreated hepatocellular carcinoma: An analysis of nationwide data
por: Kwon, Min Jung, et al.
Publicado: (2023)

Surgical outcome of laparoscopic hepatic resection for hepatocellular carcinoma: A matched case–control study with propensity score matching
por: Iwata, Tsutomu, et al.
Publicado: (2018)

Clinical features and survival outcomes of ocular melanoma in a multi-ethnic Asian cohort
por: Tan, Laura Ling Ying, et al.
Publicado: (2020)

Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting
por: Kraskowski, Oliver, et al.
Publicado: (2023)

Impact of COVID-19 on 1-Year Survival Outcomes in Hepatocellular Carcinoma: A Multicenter Cohort Study
por: De Souza, Shuell, et al.
Publicado: (2023)

Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: a multi-center comparative study
por: Pinato, David J., et al.
Publicado: (2016)

Systemic release of osteoprotegerin during oxaliplatin-containing induction chemotherapy and favorable systemic outcome of sequential radiotherapy in rectal cancer
por: Meltzer, Sebastian, et al.
Publicado: (2016)

Therapeutic Modifications without Discontinuation of Atezolizumab Plus Bevacizumab Therapy Are Associated with Favorable Overall Survival and Time to Progression in Patients with Unresectable Hepatocellular Carcinoma
por: Tokunaga, Takayuki, et al.
Publicado: (2023)

The survival outcomes and prognostic factors of hepatocellular carcinoma among type 2 diabetes patients: a two-centre retrospective cohort study
por: AZIT, Noor Atika, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p0p4d45pfqc98lrgcstfk0fo11